Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo, not anyone can get Mounjaro. In the UK, tirzepatide is a prescription-only medicine, and a prescriber must assess whether it is clinically appropriate for you before it can be dispensed. The licence covers adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related health condition, used alongside a reduced-calorie diet and increased physical activity. Even within those numbers, individual health history shapes every decision. There is no shortcut around that clinical step, and that is by design: getting a prescription for a medicine like this is a safeguard, not a formality. Learn more about how tirzepatide works if you want the mechanism first, or read on for the full eligibility picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misunderstanding about Mounjaro eligibility is that reaching BMI 30 is a green light. It is the threshold for the prescription, but meeting it does not guarantee approval. A prescriber looks at the whole picture: what else is going on with your health, what medicines you already take, whether there are conditions in your history that make tirzepatide unsuitable.
The licence excludes people with a personal or family history of medullary thyroid carcinoma, or a condition called Multiple Endocrine Neoplasia syndrome type 2. A history of pancreatitis, or certain gastrointestinal conditions, requires careful prescriber consideration. Mounjaro is not licensed for anyone under 18, and it is not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive. These are not arbitrary rules; they reflect what the clinical evidence does and does not support.
The NICE guidance on tirzepatide (NICE Technology Appraisal TA1026) sets NHS-specific eligibility criteria that are stricter than the licence, requiring a BMI of 35 or above plus at least one weight-related comorbidity. Private prescribing follows the licensed thresholds, which is why a regulated private service like Mounjaro through a GPhC-registered pharmacy can be an option for people who meet the licence but not the NHS criteria.
The licensed eligibility for Mounjaro in the UK covers adults (people aged 18 and over) with a BMI of 30 kg/m² or above. If your BMI sits between 27 and 29.9, you can still be considered if you have at least one weight-related health condition. Conditions that count include type 2 diabetes, high blood pressure, dyslipidaemia (raised cholesterol or triglycerides), obstructive sleep apnoea, and cardiovascular disease, among others.
For South Asian, Chinese, Middle Eastern, Black African and African-Caribbean backgrounds, UK guidance typically applies thresholds that are 2.5 kg/m² lower, recognising that cardiometabolic risk can present at lower body weights in these groups. So a BMI of 27.5, for example, may meet the standard for someone in one of those groups where 30 would otherwise apply.
It is worth being honest about what BMI is: a population-level screening tool, not a complete health assessment. A prescriber weighs it alongside everything else. If you are unsure where you sit, the NHS BMI calculator gives you a starting figure, and a consultation gives you a real answer. Our page on who can take Mounjaro covers contraindications in more detail.
Because Mounjaro is prescription-only, the only legal route to getting it in the UK is through a prescriber, whether that is your GP, a specialist, or a GPhC-registered online prescribing service. A legitimate process includes an assessment of your BMI and health history, a check of your current medications for interactions, and identity verification. It is not a case of filling in a quick form and receiving a package the next day regardless of the answers.
At nume, every consultation is read by a GPhC-registered Independent Prescriber. Not software, not an automated scoring system, a real clinician. If you order before noon on a working day and are clinically approved, your treatment goes out the same day, arriving with DPD the following working day in plain, unbranded packaging. You can verify our pharmacy on the GPhC register directly: registration number 9012878.
People often ask about the cost side of this. The honest answer is that legitimate private treatment is not cheap, and it is not designed to be. If you want to understand what current private prices look like and what they should include, our Mounjaro price comparison page sets it out plainly. One thing our prescribers hear regularly: patients who tried an informal route first, then came to us having lost confidence in what they received. Supply chain and clinical oversight matter more than price.
If your BMI is below 27 and you have no qualifying weight-related condition, Mounjaro is not licensed for you in the UK and a responsible prescriber will not issue a prescription. This is not a case where a different pharmacy will say yes, or should. Some people explore this as a cosmetic route; the MHRA has been direct that GLP-1 medicines are not assessed for quick or cosmetic weight loss, and a prescriber issuing one outside the licence puts both their registration and the patient at risk.
That said, the thresholds cover a wide range of people. Results in clinical trials varied considerably across participants, and not everyone loses the same amount. If you are curious about the weight-loss trajectory people actually experience, our page on the Mounjaro weight-loss graph walks through the trial data honestly, including the people for whom results were more modest. And for anyone who has had concerns about whether this treatment works at all, our page on non-responders addresses that directly.
If you think you might be eligible, the next step is a free consultation. Our prescribers will assess your full picture and give you a clear answer either way.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.